Sipai Health Technology Co (HKSE:00314) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co 3-Year EBITDA Growth Rate?

Sipai Health Technology Co's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.22.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of Sipai Health Technology Co's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Sipai Health Technology Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sipai Health Technology Co's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's 3-Year EBITDA Growth Rate falls into.

Sipai Health Technology Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sipai Health Technology Co (HKSE:00314) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sipai Health Technology Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sipai Health Technology Co (HKSE:00314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

AX1:Germany

Address

No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN

Website

https://www.medbankshealthtech.com

Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Executives

Chang Jimmy Ching-hsin	2201 Interest of corporation controlled by you
Jeneration Group Limited	2201 Interest of corporation controlled by you
Leung Catherine Ho Yan	2202 Interest of your spouse
Purple Panther	2201 Interest of corporation controlled by you
Ma Xuguang	2501 Other
Li Ji	2501 Other
Wise Approach Investments Limited	2101 Beneficial owner
Ark Trust (hong Kong) Limited	2301 Trustee
Jpmorgan Chase & Co.	2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd.	2101 Beneficial owner
Simul International Holdings Limited	2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines